Showing results (131-140 of 487) with videos related to
Sort By:
Pageof 49
Journal of the National Cancer Institute|June 21, 1989
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiationB A Teicher, T S Herman, S A Holden, et al.Cancer Research|January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicityJ P Eder, C A Wheeler, B A Teicher, et al.In Vivo (Athens, Greece)|March 24, 1998
Prostate carcinoma response to cytotoxic therapy: in vivo resistanceB A Teicher, Y Kakeji, G Ara, et al.Radiation Research|August 1, 1997
Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suraminS T Palayoor, E A Bump, B A Teicher, et al.Cancer Treatment Reports|July 1, 1977
Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphomaS W Pitman, E FreiCancer Research|June 1, 1977
The prevention of methotrexate toxicity by thymidine infusions in humansW D Ensminger, E FreiCancer Research|July 1, 1977
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitroM M Wick, E FreiSeminars in Oncology|August 1, 1989
Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 diseaseJ R Clark, E FreiCancer Chemotherapy and Pharmacology|January 1, 1988
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activityB A Teicher, S D Bernal, S A Holden, et al.Pageof 49